X-72205067-G-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_017669.4(ERCC6L):​c.3700C>T​(p.Pro1234Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000736 in 1,208,775 control chromosomes in the GnomAD database, including 1 homozygotes. There are 23 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., 4 hem., cov: 23)
Exomes 𝑓: 0.000064 ( 1 hom. 19 hem. )

Consequence

ERCC6L
NM_017669.4 missense

Scores

1
6
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.66

Publications

0 publications found
Variant links:
Genes affected
ERCC6L (HGNC:20794): (ERCC excision repair 6 like, spindle assembly checkpoint helicase) This gene encodes a member of the SWItch/Sucrose Non-Fermentable (SWI/SNF2) family of proteins, and contains a SNF2-like ATPase domain and a PICH family domain. One distinguishing feature of this SWI/SNF protein family member is that during interphase, the protein is excluded from the nucleus, and only associates with chromatin after the nuclear envelope has broken down. This protein is a DNA translocase that is thought to bind double-stranded DNA that is exposed to stretching forces, such as those exerted by the mitotic spindle. This protein associates with ribosomal DNA and ultra-fine DNA bridges (UFBs), fine structures that connect sister chromatids during anaphase at some sites such as fragile sites, telomeres and centromeres. This gene is required for the faithful segregation of sister chromatids during mitosis, and the ATPase activity of this protein required for the resolution of UFBs before cytokinesis. [provided by RefSeq, May 2017]
PIN4 (HGNC:8992): (peptidylprolyl cis/trans isomerase, NIMA-interacting 4) This gene encodes a member of the parvulin subfamily of the peptidyl-prolyl cis/trans isomerase protein family. The encoded protein catalyzes the isomerization of peptidylprolyl bonds, and may play a role in the cell cycle, chromatin remodeling, and/or ribosome biogenesis. The encoded protein may play an additional role in the mitochondria. [provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.030458182).
BS2
High Hemizygotes in GnomAd4 at 4 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERCC6LNM_017669.4 linkc.3700C>T p.Pro1234Ser missense_variant Exon 2 of 2 ENST00000334463.4 NP_060139.2 Q2NKX8
ERCC6LNM_001009954.3 linkc.3331C>T p.Pro1111Ser missense_variant Exon 3 of 3 NP_001009954.1
PIN4NM_001170747.1 linkc.312+8163G>A intron_variant Intron 3 of 3 NP_001164218.1 Q9Y237-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERCC6LENST00000334463.4 linkc.3700C>T p.Pro1234Ser missense_variant Exon 2 of 2 1 NM_017669.4 ENSP00000334675.3 Q2NKX8

Frequencies

GnomAD3 genomes
AF:
0.000170
AC:
19
AN:
112003
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00171
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000238
AC:
43
AN:
180716
AF XY:
0.000168
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00152
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000449
GnomAD4 exome
AF:
0.0000638
AC:
70
AN:
1096720
Hom.:
1
Cov.:
31
AF XY:
0.0000525
AC XY:
19
AN XY:
362232
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26326
American (AMR)
AF:
0.00186
AC:
65
AN:
34953
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19330
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30191
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53741
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40505
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4121
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841507
Other (OTH)
AF:
0.0000869
AC:
4
AN:
46046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000170
AC:
19
AN:
112055
Hom.:
0
Cov.:
23
AF XY:
0.000117
AC XY:
4
AN XY:
34247
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30890
American (AMR)
AF:
0.00171
AC:
18
AN:
10542
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2640
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3572
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2687
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6059
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53226
Other (OTH)
AF:
0.00
AC:
0
AN:
1535
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.000189
ExAC
AF:
0.0000741
AC:
9

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 15, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.3700C>T (p.P1234S) alteration is located in exon 2 (coding exon 2) of the ERCC6L gene. This alteration results from a C to T substitution at nucleotide position 3700, causing the proline (P) at amino acid position 1234 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.29
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.090
T;T
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.71
T;T
M_CAP
Benign
0.058
D
MetaRNN
Benign
0.030
T;T
MetaSVM
Benign
-0.45
T
MutationAssessor
Uncertain
2.5
.;M
PhyloP100
3.7
PrimateAI
Benign
0.39
T
PROVEAN
Uncertain
-3.7
D;D
REVEL
Uncertain
0.32
Sift
Pathogenic
0.0
D;D
Sift4G
Uncertain
0.020
D;D
Polyphen
0.68
.;P
Vest4
0.19
MutPred
0.39
.;Gain of phosphorylation at P1234 (P = 0.0921);
MVP
0.70
MPC
0.76
ClinPred
0.22
T
GERP RS
4.6
Varity_R
0.55
gMVP
0.60
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs749928252; hg19: chrX-71424917; API